Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

completed267%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair

NCT02587403
completedphase_2

Reinforcement of Closure of Stoma Site

NCT02238964
terminatednot_applicable

Impact of ADM in Reduction of Surgical Complexity of Breast Reconstructions With Implants (Nava)

NCT01853436

Clinical Trials (3)

Showing 3 of 3 trials
NCT02587403Not Applicable

A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair

Completed
NCT02238964Phase 2

Reinforcement of Closure of Stoma Site

Completed
NCT01853436Not Applicable

Impact of ADM in Reduction of Surgical Complexity of Breast Reconstructions With Implants (Nava)

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3